KRT17 and psoriasis: IMQ-treated mice showed symptoms of psoriasis-like lesions such as erythema, scales, epidermal hyperplasia, splenomegaly, and inflammatory cell infiltration, which are also closely linked to the increasing expression of K17 [38] and K6, and the decreasing expression of K10 [40,41].